Weldon Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 5.00 M
as on 24-10-2024
- Company Age 20 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.72 Cr
as on 24-10-2024
- Satisfied Charges ₹ 5.60 Cr
as on 24-10-2024
- Revenue -10.35%
(FY 2023)
- Profit 767.47%
(FY 2023)
- Ebitda -156.88%
(FY 2023)
- Net Worth 269.81%
(FY 2023)
- Total Assets 43.13%
(FY 2023)
About Weldon Biotech (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹14.72 Cr. The company has closed loans amounting to ₹5.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Choudhary, Sunita Chaudhary, Sagar Choudhary, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397DL2004PTC124261
- Company No.
124261
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Weldon Biotech (India) Private Limited offer?
Weldon Biotech (India) Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Hematology Analyzers, Analyzers & Analytical Instruments, Elemental Analyzer, Clinical Reagents, IVDs & Analyzers, Rapid Test Kit, Biochemistry Analyzer, Cell Counter, Electrodiagnostic Instruments.
Who are the key members and board of directors at Weldon Biotech (India)?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aakash Choudhary  | Director | 17-Aug-2020 | Current |
| Anil Choudhary | Director | 22-Jan-2004 | Current |
| Sunita Chaudhary | Director | 04-Dec-2007 | Current |
| Sagar Choudhary | Director | 09-Apr-2011 | Current |
Financial Performance of Weldon Biotech (India).
Weldon Biotech (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.35% decrease. The company also saw a substantial improvement in profitability, with a 767.47% increase in profit. The company's net worth Soared by an impressive increase of 269.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Weldon Biotech (India)?
In 2023, Weldon Biotech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Sep 2024 | ₹1.50 Cr | Open |
Others Creation Date: 19 Jan 2024 | ₹3.22 Cr | Open |
Others Creation Date: 30 Jun 2022 | ₹10.00 Cr | Open |
How Many Employees Work at Weldon Biotech (India)?
Weldon Biotech (India) has a workforce of 42 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Weldon Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Weldon Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
